On April 6, 2022, Dr. Steven Hall, a member of the Board of Directors of Kymera Therapeutics, Inc. and the Compensation Committee of the Board, informed the Company that he does not intend to stand for reelection at the Company's 2022 annual meeting of stockholders Dr. Hall's intention not to stand for reelection following the end of his current term was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. The Company thanks Dr. Hall for his years of service as a director.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.24 USD | -4.09% | -4.73% | +34.49% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.49% | 2.19B | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.
- Kymera Therapeutics, Inc. Announces Executive Change